| Torcetrapib |
托彻普 |
262352-17-0 |
| LFM-A13 |
LFM-A13 |
244240-24-2 |
| JTC 801 |
N-(4-氨基-2-甲基-6-喹啉基)-2-[(4-乙基苯氧基)甲基]苯甲酰胺盐酸盐 |
244218-51-7 |
| Isavuconazole |
艾沙康唑 |
241479-67-4 |
| (αS,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-Methyl-1H-1,2,4-triazole-1-butanenitrile |
艾沙康唑中间体7 |
241479-74-3 |
| MB-05032 |
2-氨基-5-异丁基-4-[5-膦酰基-2-呋喃基]噻唑 |
261365-11-1 |
| AGN 194310 |
CS-1211 |
229961-45-9 |
| Atazanavir sulfate |
阿扎那韦硫酸盐 |
229975-97-7 |
| 2,3,4,5-Tetrahydro-7,8-dinitro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine |
2,3,4,5-四氢-7,8-二硝基-3-(三氟乙酰基)-1,5-甲桥-1H-3-苯并氮杂卓 |
230615-59-5 |
| 2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine |
2,3,4,5-四氢-3-(三氟乙酰基)-1,5-甲桥-1H-3-苯并氮杂卓 |
230615-51-7 |
| 2,6-PYRIDINEDIAMINE, N6-[2-[[4-(2,4-DICHLOROPHENYL)-5-(1H-IMIDAZOL-1-YL)-2-PYRIMIDINYL]AMINO]ETHYL]-3-NITRO- |
CHIR98014(CT98014) |
252935-94-7 |
| Orantinib (SU6668) |
orantinib |
252916-29-3 |
| CHIR-99021 |
CHIR-99021 |
252917-06-9 |
| Z-Ile-Glu-Pro-Phe-OMe |
252557-97-4 |
252557-97-4 |
| (R)-N-(2-oxo-2-(pyrrolidin-3-ylaMino)-ethyl)-3-(trifluoroMethyl)benzaMide |
(R)-N-(2-氧代-2-(吡咯烷-3-基氨基)乙基)-3-(三氟甲基)苯甲酰胺 |
226249-16-7 |
| Benzamide, N-[2-oxo-2-[[(3S)-1-(phenylmethyl)-3-pyrrolidinyl]amino]ethyl]-3-(trifluoromethyl)- |
(S)-N-(2 - ((1-苄基吡咯-3-基)氨基)-2-氧乙基)-3-(三氟甲基)苯甲酰胺 |
226228-42-8 |
| CINACALCET |
西那卡塞 |
226256-56-0 |
| Fimasartan |
非马沙坦 |
247257-48-3 |
| 4-Pyrimidinecarboxylicacid,1,6-dihydro-6-oxo-,ethylester(9CI) |
6 - 羰基-1,6 - 二氢嘧啶-4 - 羧酸乙酯 |
223788-14-5 |
| 2-Fluoro-5-Methanesulfonylbenzoic acid |
2-氟-5-甲烷磺酰基苯甲酸 |
247569-56-8 |
